⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27696 | 0.73 | — | — | |
| SCHEMBL4960198 | 0.69 | — | — | |
| SCHEMBL6310576 | 0.67 | — | — | |
| SCHEMBL13924051 | 0.67 | MAPK1 (0.33) | — | |
| SCHEMBL15474301 | 0.66 | — | — | |
| SCHEMBL13931719 | 0.64 | — | — | |
| SCHEMBL859340 | 0.64 | — | — | |
| SCHEMBL950801 | 0.63 | — | — | |
| SCHEMBL21351148 | 0.63 | — | — | |
| SCHEMBL19484518 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115513520-B | Preparation method and application of fast ion conductor based on in-situ solidification | 电子科技大学 | 2024-10-29 | — | — | CN | claimed |
| EP-1864985-A1 | NOVEL CARBAPENEM COMPOUND | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2007-12-12 | — | — | EP | claimed |
| US-7205291-B2 | High mouth absorption; antibiotics against gramnegative, grampositive bacteria espscially Staphlococcus pneumonia, Hemophilus influenza | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-04-17 | — | — | US | claimed |
| US-5747483-A | ANTIBIOTICS AND BACTERICIDES | A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE (IT) | 1998-05-05 | — | — | US | claimed |
| EP-0259087-B1 | PRODRUGS OF ANTIHYPERCHOLESTEROLEMIC COMPOUNDS | MERCK & CO. INC. (US) | 1993-04-07 | — | — | EP | claimed |
| US-4943588-A | ENZYME INHIBITORS | MERCK & CO., INC. (US) | 1990-07-24 | — | — | US | claimed |
| US-4837205-A | 1,3-DIOXANE DERIVATIVES | MERCK & CO., INC. (US) | 1989-06-06 | — | — | US | claimed |
| EP-0259087-A2 | Prodrugs of antihypercholesterolemic compounds | MERCK & CO. INC. (US) | 1988-03-09 | — | — | EP | claimed |
| JP-58069875-A | — | — | None | — | — | JP | disclosed |
| CN-115513520-B | Preparation method and application of fast ion conductor based on in-situ solidification | 电子科技大学 | 2024-10-29 | — | — | CN | disclosed |
| US-20200199097-A1 | POMALIDOMIDE DERIVATIVE AND PREPARATION METHOD THEREFOR | NANJING NORATECH PHARMACEUTICALS CO., LTD (CN) | 2020-06-25 | — | — | US | disclosed |
| US-20170301947-A1 | ALL SOLID STATE SECONDARY BATTERY, SOLID ELECTROLYTE COMPOSITION USED THEREFOR, ELECTRODE SHEET FOR BATTERY, AND METHOD FOR MANUFACTURING ELECTRODE SHEET FOR BATTERY AND ALL SOLID STATE SECONDARY BATTERY | FUJIFILM CORPORATION (JP) | 2017-10-19 | — | — | US | disclosed |
| US-20170301947-A1 | ALL SOLID STATE SECONDARY BATTERY, SOLID ELECTROLYTE COMPOSITION USED THEREFOR, ELECTRODE SHEET FOR BATTERY, AND METHOD FOR MANUFACTURING ELECTRODE SHEET FOR BATTERY AND ALL SOLID STATE SECONDARY BATTERY | FUJIFILM CORPORATION (JP) | 2017-10-19 | — | — | US | disclosed |
| US-8722255-B2 | Non-aqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | UBE INDUSTRIES, LTD. (JP) | 2014-05-13 | — | — | US | disclosed |
| EP-0259087-A2 | Prodrugs of antihypercholesterolemic compounds | MERCK & CO. INC. (US) | 1988-03-09 | — | — | EP | disclosed |
| US-4654331-A | Oral absorption enhancement of carboxylic acid pharmaceuticals using (5-alkyl-2-oxo-1,3-dioxolen-4-yl)methyl ester group | MERCK & CO., INC. (US) | 1987-03-31 | — | — | US | disclosed |
| EP-0070013-B1 | ORAL ABSORPTION ENHANCEMENT OF CARBOXYLIC ACID PHARMACEUTICALS USING (5-ALKYL-2-OXO-1,3-DIOXOLEN-4-YL)METHYL ESTER GROUP | MERCK & CO. INC. (US) | 1986-10-15 | — | — | EP | disclosed |
| US-4479947-A | Oral absorption enhancement of carboxylic acid pharmaceuticals using (5-alkyl-2-oxo-1,3-dioxolen-4-yl)methyl ester group | MERCK & CO., INC. (US) | 1984-10-30 | — | — | US | disclosed |
| JP-S5869875-A | 4-TERT-BUTYL-5-HALOMETHYL-1,3-DIOXOLEN-2-ONE AND ITS PREPARATION | KANEBO LTD | 1983-04-26 | — | — | JP | disclosed |
| EP-0070013-A1 | Oral absorption enhancement of carboxylic acid pharmaceuticals using (5-alkyl-2-oxo-1,3-dioxolen-4-yl)methyl ester group | MERCK & CO. INC. (US) | 1983-01-19 | — | — | EP | disclosed |